RxDoctor Payments Data

Warren Frank, MD

Gastroenterology · Lexington, KYNPI 1881656445

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 634 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.

$10,751in general payments, 2019–2025

Across 634 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • AbbVie$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Johnson & Johnson$1K
  • Regeneron Healthcare Solutions, Inc.$437
  • Phathom Pharmaceuticals, Inc.$365
  • plus $3K from 33 others

What the payments were for

  • Consulting fees$480%
  • Food & beverage$10,68799%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,751 in reported general payments places this provider in the 80th percentile of 207 gastroenterology providers in Kentucky.

See all gastroenterology providers in Kentucky

Medicare billing

Part B allowed, 2024
$79,267
Medicare patients
325
Services billed
817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine28$11,569
Dexlansoprazole DrDexlansoprazole11$3,982
Budesonide DrBudesonide11$2,009
Esomeprazole Magnesium17$1,149
Omeprazole94$787
Sulfasalazine11$580
Azathioprine15$329
Sucralfate11$306

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →